In our study, consistent with previous reports, we found that PPS was more strongly correlated with OS than PFS in patients with ES-SCLC receiving first-line therapy with chemotherapy plus PD-L1 inhibitors (29, 30). This evidence concerns the gene CD274 and small cell lung carcinoma.